Open0.387 | Close0.360 |
Vol / Avg.1.534M / 208.985K | Mkt Cap9.637M |
Day Range0.360 - 0.430 | 52 Wk Range0.360 - 1.390 |
Geovax Labs Stock (NASDAQ: GOVX) stock price, news, charts, stock research, profile.
Open0.387 | Close0.360 |
Vol / Avg.1.534M / 208.985K | Mkt Cap9.637M |
Day Range0.360 - 0.430 | 52 Wk Range0.360 - 1.390 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.240 | -0.320 | -0.0800 | ||||
REV | 0 |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.160 | -0.220 | -0.0600 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-11-13 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-10-09 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | 8.00 | 8.00 |
2023-08-31 | HC Wainwright & Co. | Vernon Bernardino | Reiterates | BuyBuy | Maintains | - | 8.00 |
2023-05-08 | Noble Capital Markets | Robert LeBoyer | Initiates Coverage On | Outperform | Announces | - | 6.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
GOVX | Geovax Labs | -6.84% | 9.6M |
VIRI | Virios Therapeutics | 2.81% | 12.7M |
IMRN | Immuron | 3.38% | 12.2M |
IMPL | Impel Pharmaceuticals | -11.63% | 9.1M |
DOMH | Dominari Holdings | 6.94% | 12.2M |
You can purchase shares of Geovax Labs (NASDAQ: GOVX) through any online brokerage.
Other companies in Geovax Labs’s space includes: Virios Therapeutics (NASDAQ:VIRI), Immuron (NASDAQ:IMRN), Impel Pharmaceuticals (NASDAQ:IMPL), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).
The latest price target for Geovax Labs (NASDAQ: GOVX) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 8.00 expecting GOVX to rise to within 12 months (a possible 2116.07% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Geovax Labs (NASDAQ: GOVX) is $0.361 last updated December 9, 2023 at 12:58 AM UTC.
There is no dividend information for Geovax Labs.
Geovax Labs’s Q3 earnings are confirmed for Wednesday, November 8, 2023.
There is no upcoming split for Geovax Labs.
Geovax Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.